Summary & Overview
HCPCS J2601: Vasopressin Injection, 1 Unit
HCPCS Level II code J2601 denotes a unit of injectable vasopressin (Baxter), a parenteral vasoconstrictor used in acute care settings. Nationally, this code matters because it captures utilization and billing for a high-acuity medication frequently used in intensive care, emergency, and perioperative contexts. Accurate coding of J2601 supports clinical tracking, payer adjudication, and cost analyses for vasopressor therapy. Key payers included in this coverage are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. This publication provides readers with concise benchmarks for billing and utilization patterns, clarification of clinical context for use of vasopressin, and an overview of coding considerations relevant to acute care settings. Readers will learn about standard service lines and sites of service where J2601 is billed, common modifier usage (listed separately), and how J2601 fits into medication administration workflows and reimbursement pathways. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J2601 represents an injection for vasopressin (Baxter) billed per 1 unit. This code denotes administration of a vasopressin pharmaceutical preparation used for vasoconstrictive therapy.
-
Service type: Therapeutic injection
-
Typical site of service: Hospital inpatient, hospital outpatient, emergency department, or other acute care settings where parenteral vasopressin is administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult admitted to an inpatient unit or evaluated in an emergency department with vasodilatory shock or persistent hypotension not responsive to fluid resuscitation and first-line vasopressors. The attending intensivist or emergency medicine physician orders vasopressin for hemodynamic support. Pharmacy prepares the medication per hospital policy using the supplied concentration; nursing administers intravenous bolus or continuous infusion with bedside hemodynamic monitoring. Documentation includes indication (e.g., septic shock), dose in units, start and stop times, patient response (blood pressure, urine output), infusion rate changes, and any adverse reactions. Billing uses HCPCS Level II code J2601 reported in 1-unit increments with appropriate modifiers to reflect payer, service circumstances, or wasted/returned drug when required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered to patient | Use when part of a single-dose vial or prepared dose is wasted and payer requires reporting of discarded biologic/drug units. |
JZ |